晚年抑郁症的治疗策略
Hajime Baba1,2
1Department of Psychiatry, Faculty of Medicine, Juntendo Koshigaya Hospital Juntendo University Saitama Japan.
PCN reports : psychiatry and clinical neurosciences
|June 13, 2024
概括
晚年抑郁症 (LLD) 的管理是复杂的,因为老年人面临的诊断挑战和治疗反应较差. 量身定制的,针对患者的干预措施,包括心理治疗和较新的抗抑郁药,对于有效的LLD护理至关重要.
科学领域:
- 老年病的医生 老年病的医生
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
背景情况:
- 全球人口老龄化正在增加晚年抑郁症 (LLD) 的发生率.
- 与早期成人抑郁症相比,LLD在诊断和治疗方面存在独特的挑战.
- 准确的诊断需要将LLD与痴呆症,妄想症和其他疾病区分开来.
研究的目的:
- 审查目前对晚年抑郁症的管理和治疗策略.
- 突出老年抑郁症治疗的复杂性和具体考虑因素.
- 根据治疗反应水平概述基于证据的LLD方法.
主要方法:
- 对现有关于晚年抑郁症诊断和治疗的文献的综述.
- 分析治疗策略,包括心理治疗,药物治疗和神经调节.
- 根据一线反应对进一步线路治疗进行分类.
主要成果:
- LLD的特点是治疗反应较差,复发率高于年轻人群.
- 心理社会干预,认知行为疗法和解决问题的疗法都显示出有效性.
- 建议使用较新的抗抑郁药,并仔细监测不良事件;神经调节也有益.
结论:
- 晚年抑郁症是高度异质的,需要个性化治疗计划.
- 治疗策略必须考虑患者的背景,病情和对初始疗法的反应.
- 个性化,多方面的方法对于优化LLD患者的结果至关重要.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
Treatment Strategies for Psychological Disorders
109
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
109
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Electroconvulsive Therapy
31
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
31
Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122


